Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori

Wagih A. El-Shouny ； Sameh S. Ali ； Hegazy M. Hegazy ； Manar K. Abd Elnabi ； Asmaa Ali ； Jianzhong Sun

《Journal of Traditional and Complementary Medicine》 10卷4期 (2020/07) Pp. 366-377

https://doi.org/10.1016/j.jtcme.2019.05.002

摘要

The Pan-Drug Resistant (PDR), Helicobacter pylori remains an intractable challenge in public health worldwide and this pathogenicity is mainly due to the presence of a cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA). On the other hand, plant extracts such as Syzygium aromaticum contain a diverse array of secondary metabolites, which could be potentially used to combat H. pylori pathogens. To our knowledge, this is the first report on the biomedical potential of S. aromaticum extract against cytotoxin-associated genes producing PDR H. pylori. In this investigation, out of 45 gastric antral biopsy specimens of dyspeptic patients, 20 strains were confirmed as H. pylori. Eight (40%) out of 20 strains were PDR H. pylori while the rest of the strains were Multi-Drug Resistant (MDR) strains. Genotypic analyses of PDR H. pylori strains showed that cagA and vacA genes were found to be 75% and 87.5%, respectively and m2s2 was the most common subtype of vacA gene. S. aromaticum showed a significant higher anti-H. pylori activity compared to that of Cinnamomum zeylanicum and Thymus vulgaris. Eugenol was the major phenolic compound (28.14%) detected in the methanolic extract of S. aromaticum. Clearly, results of the toxicological assessment confirmed the safety of S. aromaticum for use. Hence, these results suggest that S. aromaticum could be a new useful natural antimicrobial agent that could potentially combat cytotoxin genes-producing drug-resistant H. pylori. Moreover, these findings provide a scientific basis for the development of antimicrobial agents from traditional herbal medicines for gastroprotection against gastric ulcer.

關鍵字

Helicobacter pylori ； Drug resistance ； Cytotoxin-associated genes ； Syzygium aromaticum ； Histopathology ； Antibacterial

參考文獻

Ali SS, El-Zawawy NA, Al-Tohamy R, El-Sapagh S, Mustafa AM, Sun J. Lycium shawii Roem. & Schult.: a new bioactive antimicrobial and antioxidant agent to combat multi-drug/pan-drug resistant pathogens of wound burn infections. J Trad Complement Med. 2019. https://doi.org/10.1016/j.jtcme.2019.01.004

Suzuki K, Tanaka KSH, Yano T, et al. Deficiency of stomach-type claudin-18 in mice induces gastric tumor formation independent of H. Pylori infection. Cell Mol Gastroenterol Hepatol. 2019. https://doi.org/10.1016/j.cmgh.2019.03.003

Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009;10(2):77-84.

Raju D, Hussey S, Ang M, et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology. 2012;142(5):1160-1171.

Akazawa Y, Isomoto H, Matsushima K, et al. Endoplasmic reticulum stress contributes to Helicobacter pylori VacA-induced apoptosis. PLoS One. 2013;8(12), e82322.